Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.79)
# 538
Out of 4,572 analysts
667
Total ratings
48.7%
Success rate
17.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Buy | $92 → $89 | $55.87 | +59.30% | 11 | Jul 21, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $32.37 | $13.69 | +136.46% | 4 | Jul 9, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $51 | $39.29 | +29.80% | 6 | Jul 6, 2026 | |
| NGNE Neurogene | Maintained: Buy | $69 | $35.57 | +93.98% | 3 | Jun 30, 2026 | |
| SPRB Spruce Biosciences | Initiated Coverage: Buy | $123 | $44.99 | +173.39% | 1 | Jun 16, 2026 | |
| RZLT Rezolute | Rated: Buy | $6 → $11 | $5.31 | +107.16% | 5 | Jun 15, 2026 | |
| BNTC Benitec Biopharma | Downgraded: Hold | n/a | $11.44 | - | 2 | Jun 10, 2026 | |
| NTLA Intellia Therapeutics | Rated: Hold | n/a | $11.10 | - | 7 | Jun 10, 2026 | |
| PASG Passage Bio | Downgraded: Hold | n/a | $4.90 | - | 6 | Jun 10, 2026 | |
| PEPG PepGen | Reiterated: Buy | $7 | $2.10 | +233.33% | 4 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $6.05 | +180.99% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $2.92 | +447.95% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $3.09 | +611.97% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $7.33 | +159.21% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $43 | $27.02 | +59.14% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $30.55 | +47.30% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $327.50 | -13.28% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $7.98 | +225.81% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $27.69 | +109.46% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $33.26 | +17.26% | 2 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $4.71 | +536.94% | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $95 | $39.43 | +140.93% | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $15.88 | +38.54% | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $5 | $2.97 | +68.35% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $106 | $58.87 | +80.06% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $546 | $473.09 | +15.41% | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $55 | $25.91 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $50 | $23.89 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $47.53 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $268.74 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $24 | $5.83 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.73 | n/a | 1 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.073 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $23.60 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $5.78 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $29.65 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | CHF 3.23 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $28.12 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $30 | $15.38 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $31.61 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.52 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $2.52 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 | $23.12 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $1.82 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.16 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $4.01 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $69.36 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $14.98 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $36.28 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $96.66 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $1.5 | $1.26 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $14.24 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 | $78.45 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.3995 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $5.79 | n/a | 13 | Aug 14, 2015 |
Ionis Pharmaceuticals
Jul 21, 2026
Maintained: Buy
Price Target: $92 → $89
Current: $55.87
Upside: +59.30%
Satellos Bioscience Inc.
Jul 9, 2026
Maintained: Buy
Price Target: $32.37
Current: $13.69
Upside: +136.46%
Edgewise Therapeutics
Jul 6, 2026
Maintained: Buy
Price Target: $51
Current: $39.29
Upside: +29.80%
Neurogene
Jun 30, 2026
Maintained: Buy
Price Target: $69
Current: $35.57
Upside: +93.98%
Spruce Biosciences
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $123
Current: $44.99
Upside: +173.39%
Rezolute
Jun 15, 2026
Rated: Buy
Price Target: $6 → $11
Current: $5.31
Upside: +107.16%
Benitec Biopharma
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $11.44
Upside: -
Intellia Therapeutics
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $11.10
Upside: -
Passage Bio
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.90
Upside: -
PepGen
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.10
Upside: +233.33%
Jun 5, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $6.05
Upside: +180.99%
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $2.92
Upside: +447.95%
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $3.09
Upside: +611.97%
May 28, 2026
Maintained: Buy
Price Target: $19
Current: $7.33
Upside: +159.21%
May 8, 2026
Maintained: Buy
Price Target: $52 → $43
Current: $27.02
Upside: +59.14%
May 7, 2026
Maintained: Buy
Price Target: $45
Current: $30.55
Upside: +47.30%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $327.50
Upside: -13.28%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $7.98
Upside: +225.81%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $27.69
Upside: +109.46%
Dec 3, 2025
Maintained: Buy
Price Target: $32 → $39
Current: $33.26
Upside: +17.26%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $4.71
Upside: +536.94%
Sep 24, 2025
Maintained: Buy
Price Target: $28 → $95
Current: $39.43
Upside: +140.93%
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $15.88
Upside: +38.54%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $5
Current: $2.97
Upside: +68.35%
Aug 6, 2025
Maintained: Buy
Price Target: $110 → $106
Current: $58.87
Upside: +80.06%
Aug 6, 2025
Maintained: Buy
Price Target: $450 → $546
Current: $473.09
Upside: +15.41%
May 7, 2025
Maintained: Buy
Price Target: $78 → $55
Current: $25.91
Upside: n/a
Aug 14, 2024
Maintained: Buy
Price Target: $45 → $50
Current: $23.89
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $47.53
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $268.74
Upside: n/a
Apr 5, 2022
Maintained: Buy
Price Target: $28 → $24
Current: $5.83
Upside: n/a
Mar 17, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $2.73
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.073
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $23.60
Upside: n/a
Sep 1, 2020
Maintained: Buy
Price Target: $20
Current: $5.78
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $29.65
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: CHF 3.23
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $28.12
Upside: n/a
Aug 11, 2020
Maintained: Buy
Price Target: $36 → $30
Current: $15.38
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $31.61
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $1.52
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $2.52
Upside: n/a
Aug 6, 2020
Maintained: Buy
Price Target: $54
Current: $23.12
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $1.82
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $4.16
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $4.01
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $69.36
Upside: n/a
Dec 18, 2019
Maintained: Buy
Price Target: $2
Current: $14.98
Upside: n/a
Aug 1, 2017
Maintained: Hold
Price Target: n/a
Current: $36.28
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $96.66
Upside: n/a
Oct 20, 2016
Maintained: Hold
Price Target: $9 → $1.5
Current: $1.26
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $14.24
Upside: n/a
Oct 16, 2015
Maintained: Hold
Price Target: $63
Current: $78.45
Upside: n/a
Aug 16, 2015
Maintained: Buy
Price Target: $4
Current: $0.3995
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $5.79
Upside: n/a